<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38397731</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Safety and Efficacy of Pulmonary Rehabilitation for Long COVID Patients Experiencing Long-Lasting Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">242</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph21020242</ELocationID><Abstract><AbstractText>Due to the high prevalence and persistence of long COVID, it is important to evaluate the safety and efficacy of pulmonary rehabilitation (PR) for patients who experience long-lasting symptoms more than six months after initial COVID-19 onset. Enrolled patients were admitted for a four-week in-patient-PR due to long COVID symptoms (n = 47). The safety of PR was confirmed by the absence of adverse events. Symptom-related outcomes were evaluated pre- and post-PR with significant score changes for: 6 min walking distance (61 [28 to 103] m), quality of life (mental Short Form-12: 10 [6 to 13], and physical: 9 [6 to 12]), Montreal Cognitive Assessment (1 [0 to 3]), fatigue (MFI-20: -19 [-28 to -8]), dyspnea (DYSPNEA-12: -7 [-9 to -2] and mMRC; -1 [-1 to 0]), Nijmegen questionnaire (-8 [-11 to -5]), anxiety and depression (HADS:-4 [-5 to -2] and -2 [-4 to -1], respectively) and posttraumatic stress disorder checklist scale (-8 [-12 to -4]). At the individual level, the percentage of symptomatic patients for each outcome decreased, with a high response rate, and the number of persistent symptoms per patient was reduced from six at PR initiation to three at the end of the program. Our results show that in-PR is safe and efficient at decreasing long-lasting symptoms experienced by long COVID patients at more than six months after initial disease onset.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moine</LastName><ForeName>Esp&#xe9;rance</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4579-1323</Identifier><AffiliationInfo><Affiliation>Direction de la Recherche Clinique et de l'Innovation en Sant&#xe9;, Clariane, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molinier</LastName><ForeName>Virginie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Direction de la Recherche Clinique et de l'Innovation en Sant&#xe9;, Clariane, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castanyer</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinique du Souffle La Solane, Inicea, 66340 Oss&#xe9;ja, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvat</LastName><ForeName>Amandine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinique du Souffle La Vallonie, Inicea, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coste</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinique du Souffle La Solane, Inicea, 66340 Oss&#xe9;ja, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernet</LastName><ForeName>Antonin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinique du Souffle La Solane, Inicea, 66340 Oss&#xe9;ja, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faug&#xe9;</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinique du Souffle La Vallonie, Inicea, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magrina</LastName><ForeName>Perrine</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Clinique du Souffle La Vallonie, Inicea, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aliaga-Parera</LastName><ForeName>Joan Lluis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Clinique du Souffle La Solane, Inicea, 66340 Oss&#xe9;ja, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliver</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Direction de la Recherche Clinique et de l'Innovation en Sant&#xe9;, Clariane, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinique du Souffle La Vallonie, Inicea, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexandre</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Direction de la Recherche Clinique et de l'Innovation en Sant&#xe9;, Clariane, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heraud</LastName><ForeName>Nelly</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Direction de la Recherche Clinique et de l'Innovation en Sant&#xe9;, Clariane, 34700 Lod&#xe8;ve, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MCIDs</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">multidisciplinary intervention</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">treatability</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38397731</ArticleId><ArticleId IdType="pmc">PMC10888408</ArticleId><ArticleId IdType="doi">10.3390/ijerph21020242</ArticleId><ArticleId IdType="pii">ijerph21020242</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sant&#xe9; Publique France . R&#xe9;sultats de L&#x2019;enqu&#xea;te Affection Post-COVID. Sant&#xe9; Publique France; Saint-Maurice, France: 2022. L&#x2019;affection post-COVID-19 (appel&#xe9;e aussi COVID long) en France. 22 Mars&#x2013;8 Avril 2022.</Citation></Reference><Reference><Citation>Office for National Statistics . Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK 5 January 2023. Office for National Statistics; Newport, UK: 2023. Statistical Bulletin.</Citation></Reference><Reference><Citation>National Center for Health Statistics. U.S. Census Bureau  Long COVID. Household Pulse Survey, 2022&#x2013;2023.  [(accessed on 30 January 2023)]; Available online:  https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm.</Citation></Reference><Reference><Citation>Carod-Artal F.J. Post-COVID-19 syndrome: Epidemiology, diagnostic criteria and pathogenic mechanisms involved. Rev. Neurol. 2021;72:384&#x2013;396. doi: 10.33588/rn.7211.2021230.</Citation><ArticleIdList><ArticleId IdType="doi">10.33588/rn.7211.2021230</ArticleId><ArticleId IdType="pubmed">34042167</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis. 2023;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., Townsend L., Savinelli S., Mallon P.W. Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets. Front. Mol. Biosci. 2023;10:1157651. doi: 10.3389/fmolb.2023.1157651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2023.1157651</ArticleId><ArticleId IdType="pmc">PMC10171433</ArticleId><ArticleId IdType="pubmed">37179568</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki A., Putrino D. Why we need a deeper understanding of the pathophysiology of long COVID. Lancet Infect. Dis. 2023;23:393&#x2013;395. doi: 10.1016/S1473-3099(23)00053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00053-1</ArticleId><ArticleId IdType="pmc">PMC9928485</ArticleId><ArticleId IdType="pubmed">36967698</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran V.T., Porcher R., Pane I., Ravaud P. Course of post COVID-19 disease symptoms over time in the ComPaRe long COVID prospective e-cohort. Nat. Commun. 2022;13:1812. doi: 10.1038/s41467-022-29513-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29513-z</ArticleId><ArticleId IdType="pmc">PMC8983754</ArticleId><ArticleId IdType="pubmed">35383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Jiang H., Xie Y., Zhang T., Liu S., Wu S., Sun Q., Song S., Wang W., Deng X., et al. Long-term clinical prognosis of human infections with avian influenza A(H7N9) viruses in China after hospitalization. EClinicalMedicine. 2020;20:100282. doi: 10.1016/j.eclinm.2020.100282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100282</ArticleId><ArticleId IdType="pmc">PMC7152818</ArticleId><ArticleId IdType="pubmed">32300739</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wu J., Hao S., Yang M., Lu X., Chen X., Li L. Long term outcomes in survivors of epidemic Influenza A (H7N9) virus infection. Sci. Rep. 2017;7:17275. doi: 10.1038/s41598-017-17497-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17497-6</ArticleId><ArticleId IdType="pmc">PMC5722861</ArticleId><ArticleId IdType="pubmed">29222500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D.C., Halpin S., Lewthwaite P., Salawu A., Eyre L., Breen A., O&#x2019;Connor R., Jones A., et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J. Rehabil. Med. 2020;52:jrm00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M.H., Wing Y.K., Yu M.W., Leung C.M., Ma R.C., Kong A.P., So W.Y., Fong S.Y., Lam S.P. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau H.M., Ng G.Y., Jones A.Y., Lee E.W., Siu E.H., Hui D.S. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust. J. Physiother. 2005;51:213&#x2013;219. doi: 10.1016/S0004-9514(05)70002-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0004-9514(05)70002-7</ArticleId><ArticleId IdType="pmc">PMC7130114</ArticleId><ArticleId IdType="pubmed">16321128</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long COVID: WHO calls on countries to offer patients more rehabilitation. BMJ. 2021;372:n405. doi: 10.1136/bmj.n405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n405</ArticleId><ArticleId IdType="pubmed">33568362</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Herck M., Antons J., Vercoulen J.H., Goertz Y.M.J., Ebadi Z., Burtin C., Janssen D.J.A., Thong M.S.Y., Otker J., Coors A., et al. Pulmonary Rehabilitation Reduces Subjective Fatigue in COPD: A Responder Analysis. J. Clin. Med. 2019;8:1264. doi: 10.3390/jcm8081264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8081264</ArticleId><ArticleId IdType="pmc">PMC6722504</ArticleId><ArticleId IdType="pubmed">31434343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ries A., California Pulmonary Rehabilitation Collaborative Group Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California. J. Cardiopulm. Rehabil. 2004;24:52&#x2013;62. doi: 10.1097/00008483-200401000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00008483-200401000-00010</ArticleId><ArticleId IdType="pubmed">14758104</ArticleId></ArticleIdList></Reference><Reference><Citation>Manal M.F.I., Tawfek N.R., Gamal L.M., Abdelbaky M.M. Effect of Rehabilitation Protocol on Dyspnea and Fatigue for Patients with Chronic Obstructive Pulmonary Disease. Minia Sci. Nurs. J. 2018;4:104&#x2013;114. doi: 10.21608/msnj.2018.187776.</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/msnj.2018.187776</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., et al. Symptoms, complications and management of long COVID: A review. J. R. Soc. Med. 2021;114:428&#x2013;442. doi: 10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Gloeckl R., Leitl D., Jarosch I., Schneeberger T., Nell C., Stenzel N., Vogelmeier C.F., Kenn K., Koczulla A.R. Benefits of pulmonary rehabilitation in COVID-19: A prospective observational cohort study. ERJ Open Res. 2021;7:00108. doi: 10.1183/23120541.00108-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00108-2021</ArticleId><ArticleId IdType="pmc">PMC7957293</ArticleId><ArticleId IdType="pubmed">34095290</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S., Moik F., Klok F.A., Gattinger D., Petrovic M., Vonbank K., Koczulla A.R., Ay C., Zwick R.H. Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life. Respiration. 2022;101:593&#x2013;601. doi: 10.1159/000522118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamburlani M., Cuscito R., Servadio A., Galeoto G. Effectiveness of Respiratory Rehabilitation in COVID-19&#x2019;s Post-Acute Phase: A Systematic Review. Healthcare. 2023;11:1071. doi: 10.3390/healthcare11081071.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare11081071</ArticleId><ArticleId IdType="pmc">PMC10137696</ArticleId><ArticleId IdType="pubmed">37107905</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes A.W., Goertz Y.M.J., Van Herck M., Machado F.V.C., Meys R., Delbressine J.M., Houben-Wilke S., Gaffron S., Maier D., Burtin C., et al. Recovery from COVID-19: A sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. 2021;7:00141. doi: 10.1183/23120541.00141-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00141-2021</ArticleId><ArticleId IdType="pmc">PMC8012818</ArticleId><ArticleId IdType="pubmed">34041295</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M., Vink-Niese F. Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID? Healthcare. 2022;10:392. doi: 10.3390/healthcare10020392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10020392</ArticleId><ArticleId IdType="pmc">PMC8872229</ArticleId><ArticleId IdType="pubmed">35207003</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit M.A., Singh S.J., Garvey C., ZuWallack R., Nici L., Rochester C., Hill K., Holland A.E., Lareau S.C., Man W.D., et al. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013;188:e13&#x2013;e64. doi: 10.1164/rccm.201309-1634ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201309-1634ST</ArticleId><ArticleId IdType="pubmed">24127811</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove A.M., Lynch A.D., DePaul S.M., Terhorst L., Irrgang J.J., Fitzgerald G.K. Test-Retest Reliability of Rating of Perceived Exertion and Agreement With 1-Repetition Maximum in Adults. J. Orthop. Sports Phys. Ther. 2016;46:768&#x2013;774. doi: 10.2519/jospt.2016.6498.</Citation><ArticleIdList><ArticleId IdType="doi">10.2519/jospt.2016.6498</ArticleId><ArticleId IdType="pubmed">27494056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall G.L., Filipow N., Ruppel G., Okitika T., Thompson B., Kirkby J., Steenbruggen I., Cooper B.G., Stanojevic S. Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry. Eur. Respir. J. 2021;57:2000289. doi: 10.1183/13993003.00289-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00289-2020</ArticleId><ArticleId IdType="pubmed">33707167</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer P.H., Stanojevic S., Cole T.J., Baur X., Hall G.L., Culver B.H., Enright P.L., Hankinson J.L., Ip M.S., Zheng J., et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: The global lung function 2012 equations. Eur. Respir. J. 2012;40:1324&#x2013;1343. doi: 10.1183/09031936.00080312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanney M.P., Miller M.R. Adopting universal lung function reference equations. Eur. Respir. J. 2013;42:901&#x2013;903. doi: 10.1183/09031936.00123613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00123613</ArticleId><ArticleId IdType="pubmed">24081759</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutou A.K., Asimakos A., Kortianou E., Vogiatzis I., Tzouvelekis A. Long COVID-19 Pulmonary Sequelae and Management Considerations. J. Pers. Med. 2021;11:838. doi: 10.3390/jpm11090838.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11090838</ArticleId><ArticleId IdType="pmc">PMC8469288</ArticleId><ArticleId IdType="pubmed">34575615</ArticleId></ArticleIdList></Reference><Reference><Citation>Yorke J., Swigris J., Russell A.-M., Moosavi S.H., Kwong G.N.M., Longshaw M., Jones P.W. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest. 2011;139:159&#x2013;164. doi: 10.1378/chest.10-0693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-0693</ArticleId><ArticleId IdType="pmc">PMC3035488</ArticleId><ArticleId IdType="pubmed">20595454</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaumont M., Couturaud F., Jego F., Pichon R., Le Ber C., Peran L., Roge C., Renault D., Narayan S., Reychler G. Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire. Int. J. Chron. Obstruct. Pulmon. Dis. 2018;13:1399&#x2013;1405. doi: 10.2147/COPD.S145048.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S145048</ArticleId><ArticleId IdType="pmc">PMC5933336</ArticleId><ArticleId IdType="pubmed">29750026</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler D.A., Wells C.K. Evaluation of Clinical Methods for Rating Dyspnea. Chest. 1988;93:580&#x2013;586. doi: 10.1378/chest.93.3.580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.93.3.580</ArticleId><ArticleId IdType="pubmed">3342669</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile S., Delarozi&#xe8;re J., Favre F., Sambuc R., San Marco J. Validation of the French &#x2018;multidimensional fatigue inventory&#x2019;(MFI 20) Eur. J. Cancer Care. 2003;12:58&#x2013;64. doi: 10.1046/j.1365-2354.2003.00295.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2354.2003.00295.x</ArticleId><ArticleId IdType="pubmed">12641557</ArticleId></ArticleIdList></Reference><Reference><Citation>Smets E., Garssen B., Bonke B.d., De Haes J. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J. Psychosom. Res. 1995;39:315&#x2013;325. doi: 10.1016/0022-3999(94)00125-O.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(94)00125-O</ArticleId><ArticleId IdType="pubmed">7636775</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;pine J., Godchau M., Brun P., Lemp&#xe9;ri&#xe8;re T. &#xc9;valuation de l&#x2019;anxi&#xe9;t&#xe9; et de la d&#xe9;pression chez des patients hospitalis&#xe9;s dans un service de m&#xe9;decine interne. Ann Med Psychol. 1985;143:175&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">4037594</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;pine J.P., Godchau M., Brun P. Anxiety and depression in inpatients. Lancet. 1985;2:1425&#x2013;1426. doi: 10.1016/S0140-6736(85)92589-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(85)92589-9</ArticleId><ArticleId IdType="pubmed">2867417</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983;67:361&#x2013;370. doi: 10.1111/j.1600-0447.1983.tb09716.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0447.1983.tb09716.x</ArticleId><ArticleId IdType="pubmed">6880820</ArticleId></ArticleIdList></Reference><Reference><Citation>Weathers F.W., Litz B.T., Herman D.S., Huska J.A., Keane T.M. The PTSD Checklist (PCL): Reliability, validity, and diagnostic utility; Proceedings of the Annual Convention of the International Society for Traumatic Stress Studies; San Antonio, TX, USA. 24&#x2013;27 October 1993.</Citation></Reference><Reference><Citation>Yao S.-N., Cottraux J., Note I., Mey-Guillard D., Mollard E., Ventureyra V. &#xc9;valuation des &#xe9;tats de stress post-traumatique: Validation d&#x2019;une &#xe9;chelle, la PCLS. L&#x2019;Enc&#xe9;phale Rev. De Psychiatr. Clin. Biol. Et Th&#xe9;rapeutique. 2003;29:232&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">12876547</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dixhoorn J., Duivenvoorden H.J. Efficacy of Nijmegen Questionnaire in recognition of the hyperventilation syndrome. J. Psychosom. Res. 1985;29:199&#x2013;206. doi: 10.1016/0022-3999(85)90042-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-3999(85)90042-X</ArticleId><ArticleId IdType="pubmed">4009520</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., B&#xe9;dirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware Jr J.E., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med. Care. 1996;34:220&#x2013;233. doi: 10.1097/00005650-199603000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199603000-00003</ArticleId><ArticleId IdType="pubmed">8628042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachasson D., Villiot-Danger E., Verges S., Hayot M., Perez T., Chambellan A., Wuyam B. [Maximal isometric voluntary quadriceps strength assessment in COPD] Rev. Mal. Respir. 2014;31:765&#x2013;770. doi: 10.1016/j.rmr.2013.10.645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmr.2013.10.645</ArticleId><ArticleId IdType="pubmed">25391511</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement N.D., Weir D., Holland J., Gerrand C., Deehan D.J. Meaningful changes in the Short Form 12 physical and mental summary scores after total knee arthroplasty. Knee. 2019;26:861&#x2013;868. doi: 10.1016/j.knee.2019.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.knee.2019.04.018</ArticleId><ArticleId IdType="pubmed">31109846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouquette A., Blanchin M., S&#xe9;bille V., Guillemin F., C&#xf4;t&#xe9; S.M., Falissard B., Hardouin J.B. The minimal clinically important difference determined using item response theory models: An attempt to solve the issue of the association with baseline score. J. Clin. Epidemiol. 2014;67:433&#x2013;440. doi: 10.1016/j.jclinepi.2013.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2013.10.009</ArticleId><ArticleId IdType="pubmed">24447591</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinten C., Kenis C., Decoster L., Debruyne P.R., De Groof I., Focan C., Cornelis F., Verschaeve V., Bachmann C., Bron D., et al. Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery. Qual. Life Res. 2019;28:663&#x2013;676. doi: 10.1007/s11136-018-2062-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-018-2062-6</ArticleId><ArticleId IdType="pubmed">30511255</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung Y.T., Foo Y.L., Shwe M., Tan Y.P., Fan G., Yong W.S., Madhukumar P., Ooi W.S., Chay W.Y., Dent R.A., et al. Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patients. J. Clin. Epidemiol. 2014;67:811&#x2013;820. doi: 10.1016/j.jclinepi.2013.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2013.12.011</ArticleId><ArticleId IdType="pubmed">24656406</ArticleId></ArticleIdList></Reference><Reference><Citation>van Veen R., Wieske L., Lucke I., Adrichem M.E., Merkies I.S.J., van Schaik I.N., Eftimov F. Assessing deterioration using impairment and functional outcome measures in chronic inflammatory demyelinating polyneuropathy: A post-hoc analysis of the immunoglobulin overtreatment in CIDP trial. J. Peripher. Nerv. Syst. 2022;27:144&#x2013;158. doi: 10.1111/jns.12497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12497</ArticleId><ArticleId IdType="pmc">PMC9321849</ArticleId><ArticleId IdType="pubmed">35507446</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman S., Ding K., Chow E., Meyer R.M., van der Linden Y.M., Roos D., Hartsell W.F., Hoskin P., Wu J.S.Y., Nabid A., et al. Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases. Qual. Life Res. 2018;27:1089&#x2013;1098. doi: 10.1007/s11136-017-1745-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-017-1745-8</ArticleId><ArticleId IdType="pubmed">29188483</ArticleId></ArticleIdList></Reference><Reference><Citation>Polkey M.I., Spruit M.A., Edwards L.D., Watkins M.L., Pinto-Plata V., Vestbo J., Calverley P.M., Tal-Singer R., Agusti A., Bakke P.S., et al. Six-minute-walk test in chronic obstructive pulmonary disease: Minimal clinically important difference for death or hospitalization. Am. J. Respir. Crit. Care Med. 2013;187:382&#x2013;386. doi: 10.1164/rccm.201209-1596OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201209-1596OC</ArticleId><ArticleId IdType="pubmed">23262518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kean C.O., Birmingham T.B., Garland S.J., Bryant D.M., Giffin J.R. Minimal Detectable Change in Quadriceps Strength and Voluntary Muscle Activation in Patients with Knee Osteoarthritis. Arch. Phys. Med. Rehabil. 2010;91:1447&#x2013;1451. doi: 10.1016/j.apmr.2010.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2010.06.002</ArticleId><ArticleId IdType="pubmed">20801266</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbers R.G., van Wegen E.E.H., Verhoef J., Kwakkel G. Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson&#x2019;s disease. Park. Relat. Disord. 2012;18:532&#x2013;536. doi: 10.1016/j.parkreldis.2012.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2012.01.024</ArticleId><ArticleId IdType="pubmed">22361576</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstrom M.P., Bornefalk H., Skold C.M., Janson C., Blomberg A., Bornefalk-Hermansson A., Igelstrom H., Sandberg J., Sundh J. Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease. J. Pain Symptom Manag. 2020;60:968&#x2013;975.E1. doi: 10.1016/j.jpainsymman.2020.05.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpainsymman.2020.05.028</ArticleId><ArticleId IdType="pubmed">32512047</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira A., Machado A., Marques A. Minimal Important and Detectable Differences of Respiratory Measures in Outpatients with AECOPD(&#x2020;) Copd. 2018;15:479&#x2013;488. doi: 10.1080/15412555.2018.1537366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15412555.2018.1537366</ArticleId><ArticleId IdType="pubmed">30512981</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Chair S.Y., Thompson D.R., Twinn S.F. A psychometric evaluation of the Chinese version of the Hospital Anxiety and Depression Scale in patients with coronary heart disease. J. Clin. Nurs. 2009;18:1908&#x2013;1915. doi: 10.1111/j.1365-2702.2008.02736.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2702.2008.02736.x</ArticleId><ArticleId IdType="pubmed">19638050</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehabilitation Institute of Chicago  Hospital Anxiety and Depression Scale.  [(accessed on 19 June 2023)].  Available online:  https://www.sralab.org/rehabilitation-measures/hospital-anxiety-and-depression-scale.</Citation></Reference><Reference><Citation>Feeney J., Savva G.M., O&#x2019;Regan C., King-Kallimanis B., Cronin H., Kenny R.A. Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults. J. Alzheimer&#x2019;s Dis. 2016;53:1107&#x2013;1114. doi: 10.3233/JAD-160248.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160248</ArticleId><ArticleId IdType="pubmed">27258421</ArticleId></ArticleIdList></Reference><Reference><Citation>Souto-Miranda S., Rocha V., Mendes M.A., Simao P., Martins V., Spruit M.A., Marques A. The presence of extra-pulmonary treatable traits increases the likelihood of responding to pulmonary rehabilitation. Respir. Med. 2023;206:107086. doi: 10.1016/j.rmed.2022.107086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.107086</ArticleId><ArticleId IdType="pubmed">36516547</ArticleId></ArticleIdList></Reference><Reference><Citation>Troosters T., Gosselink R., Decramer M. Six minute walking distance in healthy elderly subjects. Eur. Respir. J. 1999;14:270&#x2013;274. doi: 10.1034/j.1399-3003.1999.14b06.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-3003.1999.14b06.x</ArticleId><ArticleId IdType="pubmed">10515400</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland A.E., Nici L. The return of the minimum clinically important difference for 6-minute-walk distance in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2013;187:335&#x2013;336. doi: 10.1164/rccm.201212-2191ED.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201212-2191ED</ArticleId><ArticleId IdType="pubmed">23418323</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandre F., Heraud N., Tremey E., Oliver N., Bourgouin D., Varray A. Specific motor cortex hypoexcitability and hypoactivation in COPD patients with peripheral muscle weakness. BMC Pulm. Med. 2020;20:1&#x2013;13. doi: 10.1186/s12890-019-1042-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-019-1042-0</ArticleId><ArticleId IdType="pmc">PMC6942311</ArticleId><ArticleId IdType="pubmed">31900129</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaidya T., Beaumont M., de Bisschop C., Bazerque L., Le Blanc C., Vincent A., Ouksel H., Chambellan A. Determining the minimally important difference in quadriceps strength in individuals with COPD using a fixed dynamometer. Int. J. Chron. Obstruct. Pulmon. Dis. 2018;13:2685&#x2013;2693. doi: 10.2147/COPD.S161342.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S161342</ArticleId><ArticleId IdType="pmc">PMC6124469</ArticleId><ArticleId IdType="pubmed">30214186</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones P.W., Brusselle G., Dal Negro R.W., Ferrer M., Kardos P., Levy M.L., Perez T., Soler-Cataluna J.J., van der Molen T., Adamek L., et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir. Med. 2011;105:57&#x2013;66. doi: 10.1016/j.rmed.2010.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2010.09.004</ArticleId><ArticleId IdType="pubmed">20932736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes J., Ara&#xfa;jo H.A.G.D.O., Smaili S.M. Brazilian version of the Multidimensional Fatigue Inventory for Parkinson&#x2019;s disease. Fisioter. Mov. 2020;33:e003362. doi: 10.1590/1980-5918.033.ao61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1980-5918.033.ao61</ArticleId></ArticleIdList></Reference><Reference><Citation>Goligher E.C., Pouchot J., Brant R., Kherani R.B., Avi&#xf1;a-Zubieta J.A., Lacaille D., Lehman A.J., Ensworth S., Kopec J., Esdaile J.M., et al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J. Rheumatol. 2008;35:635&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">18322987</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordin A., Taft C., Lundgren-Nilsson A., Dencker A. Minimal important differences for fatigue patient reported outcome measures-a systematic review. BMC Med. Res. Methodol. 2016;16:62. doi: 10.1186/s12874-016-0167-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-016-0167-6</ArticleId><ArticleId IdType="pmc">PMC4937582</ArticleId><ArticleId IdType="pubmed">27387456</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global Strategy for Prevention, Diagnosis and Management of Chronic Obstructive Pulmonary Disease 2022 Report. Global Initiative for Chronic Obstructive Lung Disease; Deer Park, IL, USA: 2022.</Citation></Reference><Reference><Citation>de Torres J.P., Pinto-Plata V., Ingenito E., Bagley P., Gray A., Berger R., Celli B. Power of Outcome Measurements to Detect Clinically Significant Changes in Pulmonary Rehabilitation of Patients With COPD. Chest. 2002;121:1092&#x2013;1098. doi: 10.1378/chest.121.4.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.121.4.1092</ArticleId><ArticleId IdType="pubmed">11948037</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjelland I., Dahl A.A., Haug T.T., Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: An updated literature review. J. Psychosom. Res. 2002;52:69&#x2013;77. doi: 10.1016/S0022-3999(01)00296-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(01)00296-3</ArticleId><ArticleId IdType="pubmed">11832252</ArticleId></ArticleIdList></Reference><Reference><Citation>Smid D.E., Franssen F.M., Houben-Wilke S., Vanfleteren L.E., Janssen D.J., Wouters E.F., Spruit M.A. Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients with COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis. J. Am. Med. Dir. Assoc. 2017;18:53&#x2013;58. doi: 10.1016/j.jamda.2016.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2016.08.002</ArticleId><ArticleId IdType="pubmed">27624705</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventureyra V.A., Yao S.N., Cottraux J., Note I., De Mey-Guillard C. The validation of the Posttraumatic Stress Disorder Checklist Scale in posttraumatic stress disorder and nonclinical subjects. Psychother. Psychosom. 2002;71:47&#x2013;53. doi: 10.1159/000049343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000049343</ArticleId><ArticleId IdType="pubmed">11740168</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanovics E.A., Rosenheck R.A., Jones K.M., Huang G., Krystal J.H. Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder. Psychiatr. Q. 2018;89:141&#x2013;155. doi: 10.1007/s11126-017-9522-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11126-017-9522-y</ArticleId><ArticleId IdType="pubmed">28634644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong G.K.C., Mak J.S.Y., Wong A., Zheng V.Z.Y., Poon W.S., Abrigo J., Mok V.C.T. Minimum Clinically Important Difference of Montreal Cognitive Assessment in aneurysmal subarachnoid hemorrhage patients. J. Clin. Neurosci. 2017;46:41&#x2013;44. doi: 10.1016/j.jocn.2017.08.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2017.08.039</ArticleId><ArticleId IdType="pubmed">28887072</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q., Zheng B., Daines L., Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey R., DeMars J., Franklin K., Culos-Reed S.N., Weatherald J., Wrightson J.G. Chronic Fatigue and Postexertional Malaise in People Living with Long COVID: An Observational Study. Phys. Ther. 2022;102:pzac005. doi: 10.1093/ptj/pzac005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac005</ArticleId><ArticleId IdType="pmc">PMC9383197</ArticleId><ArticleId IdType="pubmed">35079817</ArticleId></ArticleIdList></Reference><Reference><Citation>Desachy M., Alexandre F., Varray A., Molinier V., Four E., Charbonnel L., H&#xe9;raud N. High Prevalence of Non-Responders Based on Quadriceps Force after Pulmonary Rehabilitation in COPD. J. Clin. Med. 2023;12:4353. doi: 10.3390/jcm12134353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12134353</ArticleId><ArticleId IdType="pmc">PMC10342274</ArticleId><ArticleId IdType="pubmed">37445388</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrod R., Marshall J., Barley E., Jones P.W. Predictors of success and failure in pulmonary rehabilitation. Eur. Respir. J. 2006;27:788&#x2013;794. doi: 10.1183/09031936.06.00130605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.06.00130605</ArticleId><ArticleId IdType="pubmed">16481381</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott A.S., Baltzan M.A., Fox J., Wolkove N. Success in pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Can. Respir. J. 2010;17:219&#x2013;223. doi: 10.1155/2010/203236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/203236</ArticleId><ArticleId IdType="pmc">PMC2975502</ArticleId><ArticleId IdType="pubmed">21037996</ArticleId></ArticleIdList></Reference><Reference><Citation>Spruit M.A., Augustin I.M.L., Vanfleteren L.E., Janssen D.J.A., Gaffron S., Pennings H.-J., Smeenk F., Pieters W., van den Bergh J.J., Michels A.-J., et al. Differential response to pulmonary rehabilitation in COPD: Multidimensional profiling. Eur. Respir. J. 2015;46:1625&#x2013;1635. doi: 10.1183/13993003.00350-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00350-2015</ArticleId><ArticleId IdType="pubmed">26453626</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandes N.A., Wouters E.F., Meijer K., Annegarn J., Pitta F., Spruit M.A. Reproducibility of 6-minute walking test in patients with COPD. Eur. Respir. J. 2011;38:261&#x2013;267. doi: 10.1183/09031936.00142010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00142010</ArticleId><ArticleId IdType="pubmed">21177838</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>